Concepts (92)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drug Design | 2 | 2024 | 7 | 1.690 |
Why?
|
| Breast Neoplasms | 5 | 2026 | 170 | 1.680 |
Why?
|
| Protein Phosphatase 2C | 3 | 2024 | 4 | 1.610 |
Why?
|
| Antineoplastic Agents | 2 | 2024 | 72 | 1.370 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2024 | 29 | 1.170 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2024 | 3 | 0.890 |
Why?
|
| Small Molecule Libraries | 1 | 2024 | 2 | 0.890 |
Why?
|
| Biological Availability | 1 | 2024 | 8 | 0.890 |
Why?
|
| Glucose | 2 | 2018 | 50 | 0.880 |
Why?
|
| Proteins | 1 | 2023 | 41 | 0.800 |
Why?
|
| Curcumin | 1 | 2018 | 8 | 0.570 |
Why?
|
| Animals | 7 | 2026 | 1875 | 0.570 |
Why?
|
| Enzyme Inhibitors | 1 | 2018 | 53 | 0.560 |
Why?
|
| Cell Line, Tumor | 4 | 2026 | 156 | 0.440 |
Why?
|
| Phosphorylation | 4 | 2024 | 73 | 0.430 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2026 | 38 | 0.420 |
Why?
|
| Mice | 5 | 2026 | 746 | 0.410 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 1 | 2013 | 1 | 0.400 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2013 | 48 | 0.390 |
Why?
|
| Endothelial Cells | 1 | 2013 | 17 | 0.390 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2013 | 24 | 0.390 |
Why?
|
| Signal Transduction | 3 | 2024 | 246 | 0.370 |
Why?
|
| Humans | 8 | 2026 | 6794 | 0.360 |
Why?
|
| Lipoproteins, VLDL | 1 | 2010 | 2 | 0.330 |
Why?
|
| Nerve Tissue Proteins | 1 | 2010 | 25 | 0.320 |
Why?
|
| Forkhead Transcription Factors | 1 | 2010 | 10 | 0.320 |
Why?
|
| Apoptosis | 4 | 2026 | 179 | 0.320 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2026 | 88 | 0.270 |
Why?
|
| Female | 5 | 2026 | 4060 | 0.260 |
Why?
|
| Furans | 1 | 2026 | 9 | 0.240 |
Why?
|
| Lignans | 1 | 2026 | 9 | 0.240 |
Why?
|
| Reactive Oxygen Species | 2 | 2018 | 45 | 0.240 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2024 | 3 | 0.220 |
Why?
|
| Nanotechnology | 1 | 2024 | 4 | 0.220 |
Why?
|
| Drug Delivery Systems | 1 | 2024 | 12 | 0.220 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2024 | 17 | 0.220 |
Why?
|
| Pharmaceutical Preparations | 1 | 2024 | 11 | 0.220 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 31 | 0.220 |
Why?
|
| Molecular Docking Simulation | 1 | 2023 | 2 | 0.200 |
Why?
|
| Molecular Structure | 1 | 2023 | 8 | 0.200 |
Why?
|
| Ligands | 1 | 2023 | 17 | 0.200 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2024 | 41 | 0.200 |
Why?
|
| Pancreatic Neoplasms | 1 | 2024 | 100 | 0.190 |
Why?
|
| Acetylation | 2 | 2019 | 10 | 0.180 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2019 | 1 | 0.160 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2019 | 7 | 0.160 |
Why?
|
| BRCA1 Protein | 1 | 2019 | 13 | 0.160 |
Why?
|
| DNA Damage | 1 | 2019 | 20 | 0.160 |
Why?
|
| Models, Molecular | 1 | 2018 | 6 | 0.140 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2018 | 10 | 0.140 |
Why?
|
| Hyperglycemia | 1 | 2018 | 27 | 0.140 |
Why?
|
| NF-kappa B | 1 | 2018 | 56 | 0.140 |
Why?
|
| Disease Progression | 1 | 2018 | 170 | 0.130 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 231 | 0.130 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2017 | 2 | 0.130 |
Why?
|
| Smad4 Protein | 1 | 2017 | 3 | 0.130 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2017 | 19 | 0.130 |
Why?
|
| Biomarkers, Tumor | 1 | 2017 | 51 | 0.120 |
Why?
|
| Transforming Growth Factor beta | 1 | 2017 | 55 | 0.120 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 45 | 0.120 |
Why?
|
| MCF-7 Cells | 2 | 2026 | 15 | 0.100 |
Why?
|
| Enzyme Activation | 1 | 2013 | 39 | 0.100 |
Why?
|
| Aorta | 1 | 2013 | 20 | 0.100 |
Why?
|
| Cells, Cultured | 1 | 2013 | 234 | 0.090 |
Why?
|
| Cell Movement | 2 | 2026 | 38 | 0.090 |
Why?
|
| Inflammation | 1 | 2013 | 143 | 0.090 |
Why?
|
| Cell Proliferation | 2 | 2026 | 143 | 0.090 |
Why?
|
| Transduction, Genetic | 1 | 2010 | 2 | 0.080 |
Why?
|
| Rats, Transgenic | 1 | 2010 | 2 | 0.080 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2010 | 2 | 0.080 |
Why?
|
| Hyperinsulinism | 1 | 2010 | 6 | 0.080 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2010 | 5 | 0.080 |
Why?
|
| Adenoviridae | 1 | 2010 | 8 | 0.080 |
Why?
|
| Glucose Clamp Technique | 1 | 2010 | 4 | 0.080 |
Why?
|
| Rats, Long-Evans | 1 | 2010 | 8 | 0.080 |
Why?
|
| Cell Nucleus | 1 | 2010 | 38 | 0.080 |
Why?
|
| Lipid Metabolism | 1 | 2010 | 33 | 0.080 |
Why?
|
| Up-Regulation | 1 | 2010 | 94 | 0.080 |
Why?
|
| Liver | 1 | 2010 | 157 | 0.080 |
Why?
|
| Insulin | 1 | 2010 | 146 | 0.070 |
Why?
|
| Rats | 1 | 2010 | 571 | 0.070 |
Why?
|
| Mice, Nude | 2 | 2019 | 41 | 0.070 |
Why?
|
| Mice, SCID | 1 | 2026 | 16 | 0.060 |
Why?
|
| Glycosyltransferases | 1 | 2024 | 1 | 0.050 |
Why?
|
| Proteome | 1 | 2024 | 2 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2024 | 48 | 0.050 |
Why?
|
| Biomarkers | 1 | 2024 | 214 | 0.050 |
Why?
|
| Male | 1 | 2010 | 3671 | 0.040 |
Why?
|
| Cell Cycle Proteins | 1 | 2019 | 22 | 0.040 |
Why?
|
| Ubiquitination | 1 | 2017 | 3 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2017 | 72 | 0.030 |
Why?
|
| Obesity | 1 | 2017 | 226 | 0.030 |
Why?
|